Determination of the genetic alterations, which play a role in the etiology of Barrett’s esophagus (BE), could help identify high-risk individuals for esophageal adenocarcinoma (EA). The aim of the present study was to investigate the role of oxidative DNA damage, glutathione (GSH) concentration as oxidative stress parameters and DNA repair capacity, GSTM1, SOD1 Ala16Val and OGG1 Ser326Cys genetic polymorphisms as individual susceptibility parameters in the etiology of BE. The study groups comprised BE patients who were clinically diagnosed (n = 40) and a healthy control group (n = 40). Basal DNA damage, pyrimidine and purine base damage after H2O2 induction, H 2O2 sensitivity, DNA repair capacity, oxidized pyrimidine and purine base damage repair were evaluated in peripheral blood lymphocytes with a modified comet assay using specific endonucleases (Endo III and Fpg). Polymerase chain reaction—restriction length polymorphism (PCR-RFLP)-based assays were used for genotyping. The patient group showed elevated levels of basal DNA damage, pyrimidine base damage and H2O2 sensitivity as compared to controls (p < .05). DNA repair capacity, oxidized pyrimidine and purine base damage repair capacity, were not statistically different between patients and controls. GSH concentration was found to be significantly lower in smoking patients than in the controls (p < .05). None of the genetic variations changed the risk of having BE disease. However, patients carrying the variant OGG1 Cys allele showed elevated levels of pyrimidine base damage as compared to patients carrying the wild-type OGG1 Ser (p < .05). The results of this study point to a role of oxidative DNA damage in BE. However, DNA repair capacity, GSTM1, SOD1 Ala16Val and OGG1 Ser326Cys genetic polymorphisms appeared to play no role in the individual susceptibility to this disease.
Akaa P., Mateucaa R., Buchetb JP, Thierensc H., and Kirsch-Volders M. (2004) Are genetic polymorphisms in OGG1, XRCC1 andXRCC3 genes predictive for the DNA strand break repair phenotype and genotoxicity in workers exposed to low dose ionising radiations?Mutation Research556: 169-181.
2.
Ambrosone CB, Freudenheim JL, Thompson PA, et al. (1999) Manganese superoxide dismutase (MnSOD) genetic polymorphisms, dietary antioxidants, and risk of breast cancer. Cancer Research59: 602-606.
3.
Au WW ( 2007) Usefulness of biomarkers in population studies: from exposure to susceptibility and to prediction of cancer. International Journal of Hygiene and Environmental Health210: 239-246.
4.
Beutler E., Duron O., and Kelly BM ( 1963) Improved method for the determination of blood glutathione . The Journal of Laboratory and Clinical Medicine . 61: 882-888.
5.
Bonino JA, Sharma P. ( 2005) Barrett’s esophagus. Current Opinion in Gastroenterology21: 461-465.
6.
Cadet J., Bourdat AG, D’Ham C., et al. (2000) Oxidative base damage to DNA: specificity of base excision repair enzymes. Mutation Research462: 121.
7.
Casson AG, Zheng Z., Evans SC, Veugelers PJ, Porter GA, and Guernsey DL ( 2005) Polymorphisms in DNA repair genes in the molecular pathogenesis of esophageal (Barrett) adenocarcinoma. Carcinogenesis26: 1536-1541.
8.
Casson AG, Zheng Z., Porter GA, and Guernsey DL ( 2006) Genetic polymorphisms of microsomal epoxide hydroxylase and glutathione S-transferases M1, T1 and P1, interactions with smoking, and risk for esophageal (Barrett) adenocarcinoma. Cancer Detection and Prevention30: 423-431.
9.
Chao DL, Maley CC, Wu X., et al. (2006) Mutagen sensitivity and neoplastic progression in patients with Barrett’s esophagus: a prospective analysis. Cancer Epidemiology, Biomarkers & Prevention15: 1935-1940.
10.
Clemons NJ, McColl KE, and Fitzgerald RC ( 2007) Nitric oxide and acid induce double-strand DNA breaks in Barrett’s esophagus carcinogenesis via distinct mechanisms . Gastroenterology133: 1198-1209.
11.
Collins AR, Duthie SJ, and Dobson VL ( 1993) Direct enzymic detection of endogenous oxidative base damage in human lymphocyte DNA. Carcinogenesis14: 1733-1735.
12.
Dvorak K., Fass R., Dekel R., et al. (2006) Esophageal acid exposure at pH ≤ 2 is more common in Barrett’s esophagus patients and is associated with oxidative stress. Diseases of the Esophagus19: 366-372.
13.
Dvorak K., Payne CM, Chavarria M., et al. (2007) Bile acids in combination with low pH induce oxidative stress and oxidative DNA damage: relevance to the pathogenesis of Barrett’s oesophagus. Gut56: 763-771.
14.
Ellen L.Goode, CorneliaM. Ulrich, and John D. Potter ( 2002) Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiology, Biomarkers & Prevention11: 1513-1530.
15.
Farhadi A., Fields J., Banan A., and Keshavarzian A. ( 2002) Reactive oxygen species: are they involved in the pathogenesis of GERD, Barrett’s esophagus, and the latter’s progression toward esophageal cancer?The American Journal of Gastroenterology97: 22-26.
16.
Ferguson HR, Wild CP, Anderson LA, et al. (2008) No association between hOGG1, XRCC1, and XPD polymorphisms and risk of reflux esophagitis, Barrett’s esophagus, or esophageal adenocarcinoma: results from the factors influencing the Barrett’s adenocarcinoma relationship case-control study. Cancer Epidemiology, Biomarkers & Prevention17: 736-739.
17.
Fitzgerald RC ( 2005) Complex diseases in gastroenterology and hepatology: GERD, Barrett’s, and esophageal adenocarcinoma. Clinical Gastroenterology and Hepatology3: 529-537.
18.
Hermann B., Li Y., Ray MB, Wo JM, and Martin RCG, II (2005) Association of manganese superoxide dismutase expression with progression of carcinogenesis in Barrett esophagus . Archives of Surgery140: 1204-1209.
19.
Ide H. ( 2000) DNA substrates containing defined oxidative base lesions and their application to study substrate specificities of base excision repair enzymes. Progress in Nucleic Acid Research and Molecular Biology68: 207-221.
20.
Jimenez P., Piazuelo E., Sanchez MT, Ortego J., Soteras F., and Lanas A. ( 2005) Free radicals and antioxidant systems in reflux esophagitis and Barrett’s esophagus. World Journal of Gastroenterology11: 2697-2703.
21.
Jolly AJ, Wild CP, and Hardie LJ ( 2004) Acid and bile salts induce DNA damage in human oesophageal cell lines. Mutagenesis19: 319-324.
22.
Kadioglu E., Sardas S., Aslan S., Isik E., and Karakaya AE ( 2004) Detection of oxidative DNA damage in lymphocytes of patients with Alzheimer’s disease. Biomarkers9: 203-209.
23.
Kala Z., Dolina J., Marek F., and Holla LI ( 2007) Polymorphisms of glutathione S-transferase M1, T1 and P1 in patients with reflux esophagitis and Barrett’s esophagus . Journal of Human Genetics52: 527-534.
24.
Kocabas NA, Sardas S., Cholerton S., Daly AK, Elhan AH, and Karakaya AE ( 2005) Genetic polymorphism of manganese superoxide dismutase (MnSOD) and breast cancer susceptibility. Cell Biochemistry and Function23: 73-76.
25.
Kohno T., Shinmura K., Tosaka M., et al. (1998) Genetic polymorphisms and alternative splicing of the hOGG1 gene, that is involved in the repair of 8-hydroxyguanine in damaged DNA. Oncogene16: 3219-3225.
26.
Kollarova H., Machova L., Horakova D., Janoutova G., and Janout V. ( 2007) Epidemiology of esophageal cancer- an overview article. Biomedical Papers of the Medical Faculty of the University Palacky , Olomouc, Czechoslovakia151: 17-28.
27.
Lieshout EMM, Tiemessen DM, Witteman BJM, Jansen Jbmj, and Peters WHM ( 1999) Low glutathione and glutathione S-transferase levels in Barrett’s esophagus as compared to normal esophageal epithelium. Japanese Journal of Cancer Research90: 81-85.
28.
Murphy SJ, Hughes AE, Patterson CC, Anderson LA, Watson PRG, and Johnston BT ( 2007) A population-based association study of SNPs of GSTP1, MnSOD, GPX2 and Barrett’s esophagus and esophageal adenocarcinoma . Carcinogenesis28: 1323-1328.
29.
Norppa H. ( 2003) Genetic susceptibility, biomarker responses, and cancer . Mutation Research544: 339-348.
30.
Oberg S., Wenner J., Johansson J., Walther B., and Willen R. ( 2005) Barrett esophagus: risk factors for progression to dysplasia and adenocarcinoma. Annals of Surgery242: 49-54.
31.
Olliver JR, Hardie LJ, Dexter S., Chalmers D., and Wild CP ( 2003) DNA damage levels are raised in Barrett’s oesophageal mucosa relative to the squamous epithelium of the oesophagus. Biomarkers8: 509-521.
32.
Olliver JR, Hardie LJ, Gong YY, et al. (2005) Risk factors, DNA damage, and disease progression in Barrett’s esophagus. Cancer Epidemiology, Biomarkers & Prevention14: 620-625.
33.
Olyaee M., Sontag S., Salman W., et al. (1995) Mucosal reactive oxygen species production in oesophagitis and Barrett’s oesophagus. Gut37: 168-173.
34.
Peters WH, Roelofs HM, Hectors MP, Nagengast FM, and Jansen JB ( 1993) Glutathione and glutathione S-transferases in Barrett’s epithelium. British Journal of Cancer67: 1413-1417.
35.
Raja S., Finkelstein SD, Baksh FK, et al. (2001) Correlation between dysplasia and mutations of six tumor suppressor genes in Barrett’s esophagus. The Annals of Thoracic Surgery72: 1130-1135.
36.
Rantanen TK, Rasanen JV, Sihvo EIT, Ahotupa MO, Farkkila MA, and Salo JA ( 2006) The impact of antireflux surgery on oxidative stress of esophageal mucosa caused by gastroesophageal reflux disease: 4-yr follow-up study. The American Journal of Gastroenterology101: 222-228.
37.
Rebbeck TR ( 1997) Molecular epidemiology of the human glutathione s-transferase genotypes GSTM1 and GS7T1 in cancer susceptibility. Cancer Epidemiology , Biomarkers & Prevention6: 733-743.
38.
Salminen JT, Ramo OJ, Ahotupa MO, Farkkila MA, and Salo JA ( 2002) Increased DNA adducts in Barrett’s esophagus and reflux-related esophageal malignancies. Annals of Medicine34: 565-570.
39.
Sihvo EIT, Ruohtula T., Auvinen MI, Koivistoinen A., Harjula AL, and Salo JA ( 2003) Simultaneous progression of oxidative stress and angiogenesis in malignant transformation of Barrett esophagus. The Journal of Thoracic and Cardiovascular Surgery126: 1952-1957.
40.
Sihvo EIT, Salminen JT, Rantanen TK, Ramo OJ, Ahotupa M., and Farkkila M. ( 2002) Oxidative stress has a role in malignant transformation in Barrett’s oesophagus. International Journal of Cancer102: 551-555.
41.
Toruner M., Soykan I., Ensar A., Kuzu I., Yurdaydın C., and Özden A. ( 2004) Barrett’s esophagus: prevalence and its relationship with dyspeptic symptoms. Journal of Gastroenterology and Hepatology19: 535-540.
42.
Wetscher GJ, Hinder RA, Bagchi D., et al. (1995) Reflux esophagitis in humans is mediated by oxygen-derived free radicals. American Journal of Surgery170: 552-556.
43.
Wetscher GJ, Hinder RA, Klingler P., Gadenstatter M., Perdikis G., and Hinder PR ( 1997) Reflux esophagitis in humans is a free radical event. Diseases of the Esophagus10: 29-32.
Wild CP, Lawb GR, and Romanb E. ( 2002) Molecular epidemiology and cancer: promising areas for future research in the post-genomic era. Mutation Research499: 3-12.
46.
Xing D., Tan W., and Lin D. ( 2003) Genetic polymorphisms and susceptibility to esophageal cancer among Chinese population (review). Oncology Reports10: 1615-23.
47.
Yılmaz N., Tuncer K., Tunçyürek M., Özütemiz Ö., and Bor S. ( 2006) The prevalence of Barrett’s esophagus and erosive esophagitis in a tertiary referral center in Turkey. The Turkish Journal of Gastroenterology17: 79-83.
